| Net income | |
| Gain on acquisitions (Note 1) | |
| Environmental and litigation contingencies | |
| Depreciation and amortization | |
| Equity in income from equity investments- net | |
| Employee benefit plan provisions | 2.87M |
| Stock-based compensation | 3.12M |
| Deferred income tax | -1.31M |
| Decrease (increase) in receivables | 11.74M |
| Increase in inventories | -2.95M |
| Increase in revenue in excess of billings on uncompleted contracts and other current assets | |
| (Decrease) increase in accounts payable, accrued liabilities, and accrued interest | |
| Pension contributions | |
| Other items- net | -9K |
| Net cash provided by operating activities | |
| Purchase of businesses- net of cash (Note 1) | |
| Property, plant and equipment expenditures | -23.36M |
| Proceeds from disposals of property, plant and equipment | |
| Cash pledged for collateral | |
| Cash released from collateral | |
| Net cash used in investing activities | |
| Revolving credit facility borrowings (Note 10) | 0 |
| Revolving credit facility repayments (Note 10) | 0 |
| Proceeds from debt obligations (Note 10) | |
| Reductions of debt obligations (Note 10) | |
| Treasury stock purchased | -8.64M |
| Common stock issued | |
| Excess tax benefit from stock-based compensation | |
| Net cash used in financing activities | |
| Effect of exchange rate changes on cash | |
| (Decrease) increase in cash and cash equivalents | 3.61M |
| Cash and cash equivalents, beginning of period | 53.63M |
| Cash and cash equivalents, end of period | 57.23M |